Texas Firms Save Lives and Healthcare Dollars


By Michael Wilson

Rising healthcare costs are taking their toll on American patients. Half of adults say they or a loved one skipped or delayed treatment in the past year due to cost concerns, according to the Kaiser Family Foundation. About a quarter say they or a family member has struggled to pay medical bills.

This can't go on. We need to find ways to lower the overall cost of care and help patients afford the procedures and prescriptions they need.

Fortunately, innovative businesses are working to solve this problem. By competing with entrenched incumbents and with each other, upstart firms are helping drive down costs and deliver quality care more efficiently.

Patients are spending more and more money on health care. Last year, folks who stayed overnight in the hospital saw their out-of-pocket costs spike 14 percent, according to an analysis by TransUnion Healthcare. For patients who needed same-day procedures, out-of-pocket costs rose 12 percent. Emergency department visits became 7 percent more expensive.

Why are costs surging? Well, hospital systems have increasingly consolidated in recent years. And they've bought up many formerly independent doctor practices. As a result, quasi-monopolistic providers can demand ever higher prices from insurers, employers, and patients.

Some local companies are taking on these bloated incumbents. Consider Remedy, which delivers urgent and primary medical care to patients in the comfort of their own homes.

Once a patient orders a house call from the company's site, a board-certified physician, physician assistant, or advanced practice nurse shows up at the door within two hours. Remedy medical staff answer video calls from patients within 15 minutes. These professionals provide everything from stitches and splints to prescription refills and lab tests.

Remedy gives patients with relatively minor injuries a safe, affordable alternative to the ER. House calls cost $200 without insurance. The average emergency room visit costs over 10 times as much, according to a recent claims data analysis from UnitedHealth Group.

Millions of Americans could benefit from such innovations. Right now, more than seven in ten ER visits don't actually require emergency room treatment.

DispatchHealth offers a similar service. The firm provides urgent care house calls for a price that's 80 to 90 percent less than the cost of most ER visits. The convenience factor is a top attraction. "I will definitely call them again before ever dragging myself out of the house again," said a recent customer.

My own company, Healthcare Highways, is rethinking how employers provide coverage to their employees. We work with doctors, hospitals, and insurers to provide customized, value-based healthcare options. Our plans illuminate cost drivers and help coordinate care -- which enables businesses and their employees to sustain savings.

For too long, patients have paid the price -- with their money and their health -- for America's outdated and inefficient healthcare delivery system. It's time to find new ways to provide better value in health care.

Michael Wilson is the CEO of Healthcare Highways.

More Resources


11/20/2024
What Donald Trump's Revenge Agenda Is Hiding
Look past the flashy and controversial Cabinet nominees to find that Project 2025 is already being implemented

more info


11/20/2024
Make Education Great Again!
Imagine these words as the first speech delivered by the incoming Secretary of Education.Today, I am here to deliver bitter medicine: American education has failed. Teachers and parents, administrato

more info


11/20/2024
Time-Honored Tradition of Blaming the Left for Dem Defeats
This argument is particularly unconvincing this time around. And it doesn't offer a realistic prescription for future success.

more info


11/20/2024
Dems Are Going To Get Younger and More Radical


more info


11/20/2024
The Blurred Line Between X and the Trump Administration
Forget the ridiculous

more info


11/20/2024
DOGE Is a Great Idea. Trump Should Make It Permanent
DOGE represents a harbinger of deregulation for an incoming Trump administration, especially with Dogecoin enthusiast Elon Musk and Vivek Ramaswamy at the helm.

more info


11/20/2024
The DOGE Plan To Reform Government
Following the Supreme Court's guidance, we'll reverse a decadeslong executive power grab.

more info


11/20/2024
Could Trump Actually Get Rid of the Department of Education?
Getting rid of the agency would cause a lot of harm and wouldn't really change school curriculum.

more info


11/20/2024
How Dems Are Losing Tomorrow's Elections Today
America is outgrowing the Democratic Party.

more info


11/20/2024
Can a Fractured Democratic Party Learn the Lessons of 2024?
After a bruising campaign season and a humiliating defeat at the polls, this week saw Dems' internal conflicts spilling out into public view. Party insiders are now engaged in tit-for-tat Twitter battles that do nothing to offer the party a roadmap back to political contender status. Instead, they confirm normies' worst caricatures of Democratic dysfunction.

more info


11/20/2024
Pennsylvania Voters to Sen. Casey: 'It's Over, Bob'
Columnist David Marcus talks to voters in Bucks County and finds Democrats and Republicans agree that Sen. Bob Casey's refusal to concede is a bad look.

more info


11/20/2024
NC Republicans' Shameless New Power Grab
North Carolina voters spoke loud and clear two weeks ago when they elected Democrats to some of the most prominent statewide offices.

more info


11/20/2024
Trump Can and Should Fire Jerome Powell
Legacy media have been obsessing over whether President-elect Donald Trump can remove Jerome Powell, chairman of the Federal Reserve (the Fed). Jerome Powell recently came out and stated he would serve out his term - which ends in 2026. Further, Chairman Powell claims any attempt by President Trump to remove him is not "permitted under the law." Unfortunately for Chairman Powell, President-elect Trump can remove him - and he should - to make the federal bureaucracy respond to democratic pressures once again.

more info


11/20/2024
SecDef Austin: Women in Military Make U.S. Stronger
Austin in an exclusive interview with NBC News called women in the military a strong asset. Trump's choice for Secretary of Defense has cast doubt on women in combat roles.

more info


11/20/2024
Drone, Missile Defense Top Priorities for Next Defense Secretary
Pete Hegseth faces critical challenges in addressing U.S. vulnerabilities to advanced missile and drone threats as global tensions rise.

more info



Custom Search

More Politics Articles:

Related Articles

5 Financial Pressure Points To Evaluate During COVID Times


Financial pressure is a part of life for most people, and now the COVID-19 pandemic has brought new financial pressure points or exacerbated existing ones for many individuals and families.

Why Are People Complaining About Innovative COVID Treatments?


Gilead Sciences just announced it will charge $3,120 for a full course of Remdesivir, the first new FDA-approved treatment for COVID-19. Some knee-jerk members of Congress like Lloyd Doggett (D-Tex.) immediately condemned that price tag as "outrageous." The Institute for Clinical and Economic Review, a left-leaning nonprofit that releases its own recommendations of "fair" drug prices, claimed that Gilead could afford to price Remdesivir as low as $10 per course of treatment -- the cost of the raw ingredients used to make the drug.

Proposed Healthcare Reforms Will Not Help the Latinx Community


Joe Biden is officially the Democratic presidential nominee, all thanks to his moderate reputation.

Trade Enforcement Can Accelerate America's Economic Recovery


The stock market has largely rebounded from COVID-19 and American retail sales are improving steadily. Even more encouraging is that the U.S. unemployment rate fell for the fifth consecutive month in September. Each of these gains are sure signs that the Trump administration's economic response to the coronavirus crisis is working.

Drug Price Controls: Right Objective, Wrong Solution


This month, President Trump signed an executive order to reduce Medicare spending on prescription drugs. For each medication, Medicare will pay no more than the lowest price available in other developed countries.

Keep Thanksgiving, Family and Friends Alive


Joe Biden or Donald Trump will never visit me in my home, stand beside me at the funeral home or dance at my wedding. I will not be receiving any calls from either of them to pray for me during sickness or to check on how my children are doing. I probably will never sit in a room with them to visit, laugh and tell funny stories or just to hang out over a cup of coffee. I do not personally know either one. I welcome the opportunity to visit with either of them, but doubt it will happen.

The "E" Stands for “Excellence:” Remembering Walter E. Williams


Walter E. Williams, prolific author, piercing cultural commentator, old school economist (that’s a good thing), devoted husband, loving father, and long-time friend of Grove City College has passed from this world.

How Congress Can Really Fix Surprise Billing


House and Senate leaders recently agreed on legislation to end surprise medical bills as part of a big coronavirus relief package. President Trump signed it into law at the end of December.

A Federal Rule Will Reverse Strides in Cancer Treatment


"You've got cancer." That's one of the scariest sentences in the English language.

Biden Must Restore Seniors' Access to Essential Medicines


On January 19, Medicare officials announced a new payment model that could wreak havoc on the chronically ill.

Violence In America, Don't Be Surprised


The most recent attack at the United States Capitol will most likely insure a permanent fence and additional security. The attack which resulted in the loss of life for a long serving Capitol police officer and the attacker is another senseless violent act.

Protecting the Innovation that Protects Global Health


The most far-reaching healthcare policy decision of 2021 won't be made in Congress or the White House. It will be made at the World Trade Organization, which is considering a petition to waive all patent rights on Covid-19 vaccines.

Don't Repeat Europe's Vaccine Catastrophe


For many Americans, the calamitously slow vaccine roll-out in countries like Germany, France, and Italy comes as a surprise. After all, in the early days of the pandemic, Europe's response to the crisis seemed highly competent, especially compared to the United States.

A Full Plate for the New U.S. Trade Czar


The newly confirmed U.S. trade representative, Katherine Tai, is about as qualified as a person can be for the job. Which is a good thing, because she already faces a series of challenges.

Don't Let the US Import Europe's Failed Cancer Policies


With a majority in both the House and Senate and control of the Oval Office, Democratic leaders are excited about the prospect of making significant changes. One good example of this is the House Democrats' "Lower Drug Costs Now Act."